These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 27511187

  • 1. How reliable is 18FDG PET for predicting the onset of Huntington's disease?
    Ciarmiello A.
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2180-2182. PubMed ID: 27511187
    [No Abstract] [Full Text] [Related]

  • 2. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA, Camacho V, Pérez-Pérez J, Martínez-Horta S, Fernández A, Sampedro F, Montes A, Lozano-Martínez GA, Gómez-Anson B, Kulisevsky J, Carrió I.
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [Abstract] [Full Text] [Related]

  • 3. Reversible striatal hypermetabolism in a case of rare adult-onset Sydenham chorea on two sequential 18F-FDG PET studies.
    Paghera B, Caobelli F, Giubbini R, Premi E, Padovani A.
    J Neuroradiol; 2011 Dec; 38(5):325-6. PubMed ID: 21215457
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
    Peter J, Houshmand S, Werner TJ, Rubello D, Alavi A.
    Nucl Med Commun; 2016 Aug; 37(8):882-7. PubMed ID: 27092666
    [Abstract] [Full Text] [Related]

  • 6. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS, Barret O, Jennings DL, Friedman JH, Tamagnan GD, Thomae D, Alagille D, Morley TJ, Papin C, Papapetropoulos S, Waterhouse RN, Seibyl JP, Marek KL.
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging.
    Ryu SI, Tafti BA, Skirboll SL.
    J Neuroimaging; 2010 Oct; 20(4):393-6. PubMed ID: 19453834
    [Abstract] [Full Text] [Related]

  • 15. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
    Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D.
    J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
    Michler E, Hoberück S, Martino F, Platzek I, Kotzerke J.
    Nuklearmedizin; 2019 Sep; 58(5):403-404. PubMed ID: 31344728
    [Abstract] [Full Text] [Related]

  • 17. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
    Kuwert T, Noth J, Scholz D, Schwarz M, Lange HW, Töpper R, Herzog H, Aulich A, Feinendegen LE.
    Mov Disord; 1993 Sep; 8(1):98-106. PubMed ID: 8419813
    [Abstract] [Full Text] [Related]

  • 18. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
    Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, Squitieri F.
    J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease.
    Kuwert T, Lange HW, Boecker H, Titz H, Herzog H, Aulich A, Wang BC, Nayak U, Feinendegen LE.
    J Neurol; 1993 Nov; 241(1):31-6. PubMed ID: 8138819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.